Nancy C. Braman

Nancy C. Braman is a patent litigation attorney primarily focused on high-stakes patent infringement and intellectual property disputes for life sciences and technology companies. Her practice encompasses counseling on patent procurement, portfolio development, and licensing strategies for complex life sciences technologies. Her technical background, including degrees in Molecular Biology, Biotechnology, and Microbiology, underpins her work with technologies such as antibody platforms, pharmaceuticals, biologics, CRISPR/Cas systems, therapeutic delivery mechanisms, DNA sequencing, and medical devices, including continuous positive airway pressure (CPAP) devices.

Ms. Braman typically represents operating companies, often on the defendant side or in defensive postures, such as seeking declaratory judgments of non-infringement. Her tracked appearances include representing defendants in patent infringement suits. While at DLA Piper US, she served as counsel for Hewlett Packard Enterprise Company, the plaintiff in a declaratory judgment action for non-infringement against Intellectual Ventures I LLC in the District of Delaware, where a motion to dismiss for lack of subject matter jurisdiction was denied in 2022. More recently, she has appeared as counsel for New England Biolabs in a patent infringement suit related to DNA methylation detection technology and for AURA SUB, LLC in a 2024 patent case in the District of Massachusetts.

Currently, Ms. Braman is a Senior Associate at Choate, Hall & Stewart LLP in Boston, Massachusetts. Prior to joining Choate, she practiced as an attorney and patent agent at a global law firm, which included an appearance with DLA Piper US. She also gained experience as a summer associate at Haug Partners LLP and reported on intellectual property law and policy as a journalist for IPWatchdog. While her practice involves advising on patent procurement, specific appearances in PTAB or IPR proceedings are not prominently featured in available records.

Nancy Braman is a registered patent attorney with the U.S. Patent and Trademark Office. She holds a J.D. from UNH Franklin Pierce School of Law, an M.Sc. in Biotechnology from The Johns Hopkins University, and B.Sc. degrees in Molecular Biology and Microbiology from the University of Idaho.